{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:34:24Z","timestamp":1765233264816,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.carrev.2022.02.021","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T11:34:40Z","timestamp":1645788880000},"page":"123-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["First Transcatheter Aortic Valve Replacement With Gadobutrol in a Patient With Severe Contrast Allergy"],"prefix":"10.1016","volume":"40","author":[{"given":"Vinayak","family":"Nagaraja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Adnan","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackram F.","family":"Eleid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric E.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2022.02.021_bb0005","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.02.021_bb0010","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.02.021_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.175.3.2343107","article-title":"Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media","volume":"175","author":"Katayama","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.carrev.2022.02.021_bb0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2214\/ajr.157.6.1950858","article-title":"Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment","volume":"157","author":"Bush","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009407","article-title":"Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation","volume":"14","author":"Sammour","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.02.021_bb0030","first-page":"319","article-title":"Use of gadobutrol in coronary angiography","volume":"63","author":"Voss","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.02.021_bb0035","first-page":"175","article-title":"Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures","volume":"67","author":"Briguori","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.02.021_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1540-8183.2007.00340.x","article-title":"Gadolinium-based coronary angiography in patients with contraindication for iodinated x-ray contrast medium: a word of caution","volume":"21","author":"K\u00e4lsch","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1253\/circj.69.507","article-title":"'Gadolinium' as an alternative to iodinated contrast media for X-ray angiography in patients with severe allergy","volume":"69","author":"Ose","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2022.02.021_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2214\/AJR.17.18655","article-title":"Reactions to both nonionic iodinated and gadolinium-based contrast media: incidence and clinical characteristics","volume":"210","author":"Sodagari","year":"2018","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0055","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00330-008-0977-y","article-title":"Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions","volume":"18","author":"Sieber","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/RLI.0000000000000307","article-title":"Gadobutrol in renally impaired patients: results of the GRIP study","volume":"52","author":"Michaely","year":"2017","journal-title":"Invest Radiol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.carrev.2022.02.021_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00330-012-2597-9","article-title":"Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines","volume":"23","author":"Thomsen","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.carrev.2022.02.021_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/24748706.2019.1682211","article-title":"Multi-pigtail technique is associated with decreased contrast use and fluoroscopic adjustment for transcatheter aortic valve replacement","volume":"4","author":"Eng","year":"2020","journal-title":"Struct Heart"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:23:41Z","timestamp":1761560621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838922001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":15,"alternative-id":["S1553838922001038"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2022.02.021","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Transcatheter Aortic Valve Replacement With Gadobutrol in a Patient With Severe Contrast Allergy","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2022.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}